Over the past 12 months, 9 insiders at CRESCENT BIOPHARMA, INC. filed 9 open-market SEC Form 4 transactions on CBIO: 2 purchases worth $30.6M and 7 sales worth $1.2M. Insiders have been net sellers over this period. The most recent filing was on Jul 16, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | Fairmount Funds Management LlcDirector, 10% Owner | BUY | 853.5K | $14.50 | $12.4M |
| Jun 22, 26 | Barbara Harlin BisphamSee Remarks | SELL | 1.2K | $17.99 | $22K |
| Jun 22, 26 | Joshua T BrummChief Executive Officer | SELL | 42.3K | $17.99 | $761K |
| Jun 22, 26 | Ellie Eunkyung ImChief Medical Officer | SELL | 1.2K | $17.99 | $22K |
| Jun 22, 26 | Ryan LynchSee Remarks | SELL | 465 | $17.99 | $8K |
| Jun 22, 26 | Jonathan McNeillPresident and COO | SELL | 20.5K | $17.99 | $370K |
| Jun 22, 26 | Jan PinkasChief Scientific Officer | SELL | 1.3K | $17.99 | $23K |
| Jun 22, 26 | Richard William ScalzoChief Financial Officer | SELL | 1.1K | $17.99 | $20K |
| Dec 4, 25 | Peter Evan HarwinDirector,TenPercentOwner | BUY | 1.36M | $13.41 | $18.2M |
Over the past 12 months, insiders at CRESCENT BIOPHARMA, INC. filed 2 open-market purchases worth $30.6M and 7 sales worth $1.2M on CBIO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 16, 26.
The largest recent open-market CBIO insider purchase in our data was $18.2M by Peter Evan Harwin, Director,TenPercentOwner, filed on Dec 4, 25.
9 different insiders at CRESCENT BIOPHARMA, INC. filed open-market SEC Form 4 transactions on CBIO over the last 12 months.
InsiderTape plots every CBIO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CRESCENT BIOPHARMA, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →